Quick Answer: Anti-VEGF therapy is an injectable treatment for diabetic retinopathy and diabetic macular edema (DME). It works by blocking VEGF, a protein that causes abnormal blood vessel growth and retinal swelling, helping reduce fluid buildup and slow vision loss.
What Is Anti-VEGF Therapy?
Anti-VEGF therapy is a leading injectable treatment used by retina specialists to manage diabetic eye disease.
In a healthy eye, a protein called VEGF (vascular endothelial growth factor) helps regulate blood vessel growth. However, in people with diabetes, elevated blood sugar levels can increase VEGF production in the retina.
This leads to:
-
- Leaking retinal blood vessels
- Swelling in the macula (central retina)
- Abnormal, fragile blood vessel growth
Over time, these changes can damage the retina and contribute to diabetic retinopathy progression.
Anti-VEGF medications work by blocking VEGF activity, helping reduce swelling and stabilize vision.
If you are learning how diabetes affects vision, it is also important to understand how diabetes can damage your retina.
Why Anti-VEGF Injections Are Used for Diabetic Eye Disease
Anti-VEGF injections are commonly used to treat the most vision-threatening complications of diabetes.
They are primarily used for:
Diabetic Macular Edema (DME)
Swelling in the macula that causes blurry or distorted central vision.
Proliferative Diabetic Retinopathy (PDR)
Advanced disease where abnormal blood vessels grow and may bleed or scar the retina.
These conditions occur when diabetes damages the retinal blood vessels and disrupts normal oxygen flow.
How Anti-VEGF Therapy Works in the Eye
Anti-VEGF medications block the VEGF protein responsible for abnormal blood vessel formation.
By reducing VEGF activity, this treatment helps:
-
- Decrease fluid leakage in the retina
- Reduce swelling in the macula
- Slow abnormal blood vessel growth
- Stabilize vision over time
This is why anti-VEGF therapy is often considered a first-line treatment for diabetic retinal disease.
What to Expect During Anti-VEGF Eye Injections
The procedure is quick, performed in-office, and typically well tolerated.
Step 1: Numbing the Eye
Anesthetic drops are used to ensure minimal discomfort during the injection.
Step 2: Cleaning the Eye
The surface of the eye is carefully cleaned to reduce infection risk.
Step 3: The Injection
A very small needle delivers medication into the vitreous (gel inside the eye). The injection itself takes only a few seconds.
Step 4: Aftercare
Most patients can return to normal activities the same day. Mild irritation, redness, or floaters may occur temporarily.
Do Anti-VEGF Injections Hurt?
Most patients experience little to no pain.
You may feel:
-
- Mild pressure
- Brief discomfort
- A quick sensation during injection
Since the eye is fully numbed, the procedure is generally well tolerated.
How Often Are Anti-VEGF Injections Needed?
Treatment frequency varies depending on disease severity and response.
Typical treatment patterns include:
-
- Monthly injections during the initial phase
- Gradual spacing as the retina stabilizes
- Maintenance injections as needed for long-term control
Your retina specialist will monitor progress using imaging such as OCT scans.
This is why routine monitoring is important—learn more about how often diabetics should get retinal exams.
How Effective Is Anti-VEGF Therapy?
Anti-VEGF therapy is highly effective for stabilizing diabetic eye disease.
It may:
-
- Improve vision affected by retinal swelling
- Reduce macular edema
- Slow progression of diabetic retinopathy
- Lower risk of severe vision loss
However, it is not a cure. Ongoing monitoring and repeat treatments are often required.
If you are wondering about disease progression, learn more about whether diabetic retinopathy can be reversed.
Who Needs Anti-VEGF Therapy?
You may be a candidate for anti-VEGF treatment if you have:
-
- Diabetic macular edema (DME)
- Moderate to severe diabetic retinopathy
- Vision changes due to retinal swelling
- Abnormal blood vessel growth in the retina
Diagnosis is confirmed through a dilated eye exam and retinal imaging such as OCT.
When Should You See a Retina Specialist?
You should schedule an evaluation if you experience:
-
- Blurry or fluctuating vision
- Floaters or dark spots
- Difficulty reading or focusing
- Sudden changes in vision
- A diagnosis of diabetes with vision concerns
At the Massachusetts Eye Research and Surgery Institution (MERSI), our retina specialists use advanced imaging and personalized treatment plans to diagnose and manage diabetic eye disease.
If you are looking for a retina specialist for diabetes or a diabetic eye doctor near Boston, our team provides expert care throughout Waltham and Greater Boston.
Schedule an evaluation with a diabetic retinopathy specialist near Boston to determine if anti-VEGF therapy is appropriate for you.
Anti-VEGF Therapy for Diabetic Retinopathy
Anti-VEGF therapy is a highly effective injectable treatment for diabetic retinopathy and diabetic macular edema. It helps reduce retinal swelling, slow disease progression, and protect vision when started early and monitored consistently.
Frequently Asked Questions
What is anti-VEGF treatment for diabetic retinopathy?
Anti-VEGF treatment is an injectable medication that blocks the vascular endothelial growth factor protein. This stops the growth of fragile, leaking blood vessels in the retina and reduces vision-threatening swelling in patients with diabetic eye disease.
How long does anti-VEGF treatment take?
The actual injection takes only a few seconds. However, the entire appointment usually lasts about an hour to accommodate for vision testing, retinal imaging, and allowing the numbing drops to fully take effect.
Is anti-VEGF therapy permanent?
No, anti-VEGF therapy is not a permanent cure. It is a highly effective management tool for diabetic retinopathy. Most patients require an initial monthly loading phase, followed by maintenance injections spaced out over several months to keep the disease controlled.
Can anti-VEGF restore vision?
Anti-VEGF therapy can partially improve blurry vision caused by active macular swelling (edema). However, it cannot restore vision that has been permanently lost to severe retinal scarring or long-term detachment, which highlights the need for early intervention.